<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://vettaintech.com/insights/algorithmic-dominance-2-5-trillion-factor-strategies-reshape-market-alpha-1781607762772</loc>
    <news:news>
      <news:publication>
        <news:name>Vetta Investments</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-16T11:02:42.000Z</news:publication_date>
      <news:title>Algorithmic Dominance: $2.5 Trillion Factor Strategies Reshape Market Alpha</news:title>
      <news:keywords>algorithmic factor strategies market alpha, systematic investing assets under management, long-term algorithmic market structure, factor strategies, systematic investing, market alpha, Vetta Investments, V-Rank Alpha, separately managed accounts, algorithmic equity strategy</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://vettaintech.com/research/the-cellular-scribe-in-vivo-base-editing-and-the-10-billion-quest-for-accessible-genomic-repair-1781561138305</loc>
    <news:news>
      <news:publication>
        <news:name>Vetta Investments</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T22:05:38.000Z</news:publication_date>
      <news:title>The Cellular Scribe: In-Vivo Base Editing and the $10 Billion Quest for Accessible Genomic Repair</news:title>
      <news:keywords>in-vivo base editing, sickle cell disease treatment, genomic repair accessibility, ex-vivo gene therapy cost, $10 billion market potential, BEAM therapeutics, VERV therapeutics, Casgevy cost, Lyfgenia price, genetic fault line repair</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://vettaintech.com/insights/the-alchemist-s-eye-finding-gold-in-the-market-s-unseen-veins-1781521330005</loc>
    <news:news>
      <news:publication>
        <news:name>Vetta Investments</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T11:02:10.000Z</news:publication_date>
      <news:title>The Alchemist&apos;s Eye: Finding Gold in the Market&apos;s Unseen Veins</news:title>
      <news:keywords>small cap innovation investing strategy, mid cap outperformance long term, unseen market opportunities small caps, small cap investing, mid cap growth, innovation investing, Vetta Investments, V-Rank Alpha, separately managed accounts, algorithmic equity strategy</news:keywords>
    </news:news>
  </url>
</urlset>